Current News

COVID-19 Vaccines For Children, What Is Being Considered?

BP World Bureau | Oct 13 2021 10:28:58 AM
Image credits: Twitter

COVID-19 vaccination is being considered for children. Experts recommended that Bharat Biotech's Covaxin should be given emergency use authorisation for children in the age group of two to 18 years of age.  Final approval is yet to be given by the Drugs Controller General of India (DCGI).

In the country, vaccines are given only to people who are above 18 years of age. 

Vaccination for children is being pushed after concerns regarding a possible third wave of the disease. 

Bharati Pravin Pawar, union minister of state for health and family welfare, said that the evaluation of the COVID-19 vaccine for children is under progress with discussion with experts.

Read:  Coal Shortage Sparks Concerns Over Outage in India, PM's Office to Review the Situation Today 

Vaccines that are being considered include; 

  1. ZvCoV-D by Zydus Cadila: in trials. It has been approved for use in age groups 12 and above. ZyCoV-D has received EUA from the drug regulator.
  2. Covaxin by Bharat Biotech: for use in ages 2 and above but it has not been included in the country's vaccination drive. 
  3. Corbevax by Biological E: vaccine has been cleared in the trials. 
  4. Covovax by Serum Institute of India (SII): company's chief Adar Poonawalla said that he expects Covovax, a vaccine for kids, to be approved for those below 18 years by next year.